Aculys Pharma Inc., a clinical-stage biopharmaceutical company, has appointed Hidemasa Tanigaki as Chief Executive Officer (CEO) and Representative Director, effective March 29th.   Tanigaki has been a leader in the pharmaceutical sector for over 30 years. He began his journey with Takeda Pharmaceutical Company in 1992 and held numerous key positions throughout his tenure with the company. After starting his career as a medical rep, he was later involved in the successful launch of multiple pr...